Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an insulin-independent class of oral antihyperglycemic medication and from recently established therapy in chronic heart failure patients. A rare, but potentially life-threatening complication of SGLT2 inhibitor use is euglycemic diabetic ketoac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakušić, Nenad, Sopek Merkaš, Ivana, Slišković, Ana Marija, Cerovec, Dora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627354/
https://www.ncbi.nlm.nih.gov/pubmed/36339887
http://dx.doi.org/10.4330/wjc.v14.i10.561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627354/
https://www.ncbi.nlm.nih.gov/pubmed/36339887
http://dx.doi.org/10.4330/wjc.v14.i10.561

Ejemplares similares